Dr. Maxwell Lloyd shared the importance of improving patient access to innovative therapies like Orserdu at the 2024 San Antonio Breast Cancer Symposium.

Around 1,200 people with advanced breast cancer could benefit from a decision by NICE to give the go-ahead to a new treatment ...

The U.S. Food and Drug Administration has approved AstraZeneca and partner Daiichi Sankyo's precision drug to treat a type of ...

The $30 million facility was made possible, in part, through a $4 million contribution through the AdventHealth Palm Coast ...

Even with the same cancer diagnosis personalised treatments are essential due to variations in patient health cancer ...

Dawn Klemow, MD, assistant clinical professor, University of Texas Southwestern Medical Center, previews some of the most recent advances in breast cancer treatment.

Cite this: SABCS 2024: New Treatment Options in HR+/HER2- Breast Cancer - Medscape - Jan 10, 2025.

Discover the 3 critical warning signs of breast cancer that every Black woman should know, plus insights on early detection ...

IntroductionThe global cancer therapeutics market is on an exponential growth trajectory, driven by advancements in treatment ...

The new Fast Track designation is for the treatment of advanced or metastatic breast cancer in patients with human epidermal growth factor receptor 2 (HER2) low (IHC 1+ or IHC 2+/ISH–) or HER2 ...

To gain insights into treatment options available internationally ... effectively target and destroy cancer cells. These therapies have been game-changers for advanced cancers, including cervical ...